v3.26.3
Note 1 - Nature of the Business and the Basis of Preparation (Tables)
9 Months Ended
Sep. 30, 2026
Notes Tables  
Schedule of Subsidiaries [Table Text Block]

Name of company

Place of incorporation

Date of incorporation

Percentage of ownership by the Group

Principal activities

         

BeyondSpring Pharmaceuticals Inc. (“BeyondSpring US”)

Delaware, U.S.

June 18, 2013

100%

Clinical trial activities

         

BeyondSpring Australia Pty Ltd

Australia

June 29, 2026

100%

Clinical trial activities

         

Wanchun Biotechnology Limited (“BVI Biotech”)

BVI

April 1, 2015

100%

Holding company